Skip to main content
Cyber Week Sale - Get 40% off Vantage
Get Started
SubscribeLogin
Published • loading... • Updated

Abivax Stock Soars on Trial Data for Ulcerative Colitis Drug

Summary by biopharmadive.com
The French biotech is developing a new drug approach in a disease market that’s projected to grow to $30 billion by 2030.

16 Articles

Le MondeLe Monde
Lean Left

Abivax's Tricolor Biotech Flies 520% on the Stock Exchange

The company had a historic day on Wednesday, July 23, after the announcement of positive results regarding its candidate medicine.

·Paris, France
Read Full Article
Investor's Business DailyInvestor's Business Daily
Lean Right

Biotech Skyrocket 500% On 'Potentially Disruptive' News

Shares of Abivax hit the stratosphere Wednesday after the firm unveiled "potentially disruptive" results for its ulcerative colitis drug.

Read Full Article
sherwood.newssherwood.news
Lean Left

Tiny biotech Abivax shoots up 500% on positive trial results

Abivax said it hopes to submit the drug for approval in the US and Europe in 2026....

Read Full Article
biopharmadive.combiopharmadive.com
Center

Abivax stock soars on trial data for ulcerative colitis drug

The French biotech is developing a new drug approach in a disease market that’s projected to grow to $30 billion by 2030.

Read Full Article
Le FigaroLe Figaro
Lean Right

Biotech Abivax Flies Away by More than 385% on the Paris Stock Exchange After Positive Results of Clinical Trials

The jump in his course comes after the announcement of positive results from two clinical trials advanced in chronic bowel disease.

·Paris, France
Read Full Article
STATSTAT
Center

Small biotech Abivax scores major win with ulcerative colitis trials

The drug, obefazimod, helped patients with the bowel disease enter remission. The company said it planned to file for approval next year.

·Boston, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 43% of the sources lean Left
43% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Reflector broke the news in on Tuesday, July 22, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Biotech icon

Biotech

Economy icon

Economy

Stock Markets icon

Stock Markets

Business & Markets icon

Business & Markets

Health & Medicine icon

Health & Medicine

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal